Study on Epcoritamab and Loncastuximab Tesirine for Treating Relapsed or Refractory Large B-cell Lymphoma | Clinical Trial

Study on Epcoritamab and Loncastuximab Tesirine for Treating Relapsed or Refractory Large B-cell Lymphoma | Clinical Trial | Right2Hope